Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$1.2 - $2.34 $17,400 - $33,930
-14,500 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$1.3 - $1.76 $18,850 - $25,520
14,500 New
14,500 $19,000

Others Institutions Holding CWBR

# of Institutions
1
Shares Held
1.14K
Call Options Held
0
Put Options Held
0

About CohBar, Inc.


  • Ticker CWBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,906,940
  • Market Cap $1.19M
  • Description
  • CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...
More about CWBR
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.